icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Pharmstandard posts 1H 2009 Net Profit of 2.59 billion Roubles

Pharmstandard posts 1H 2009 Net Profit of 2.59 billion Roubles
The leading Russian pharmaceutical company, Pharmstandard has posted a 1H 2009 Net Profit of 2.59 billion Roubles under IFRS.

The bottom line is up 47% from the 1H 2008 Net Result of 1.76 billion Roubles, with EBITDA up 51% year on year to 3.9 billion Roubles, as Revenues rose 62% to 10.1 billion Roubles.

The company largely attributed its better than expected results to the governmental tender for Velcade supply held in 2Q 2009, which boosted pharmaceutical products sales for Pharmstandard by 73% in 1H 2009 year on year.

Dear readers and commenters,

We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.

Sorry for the inconvenience, and looking forward to your future comments,

RT Team.